Innovation in pharmaceutical discovery and development is taking place at an astonishing pace. The genomics revolution and other advances have led to the emergence of highly effective, but extremely complex therapeutics, with cell and gene therapies, regenerative medicines and tissue therapies now transforming the prospects of patients and healthcare providers around the globe.

However there remain many strategic challenges to the effective development, deployment and utilisation of these ground-breaking medical technologies. Advanced Therapies Integrates will constitute a new forum, dedicated to bringing together the industry leaders to help drive and deliver the full potential ATMPs.

It will uniquely engage across the widest possible network: from pharma innovators, regulators, supply chain partners, equipment & technology providers, academia, industry associations, together with a wide array of government funding bodies and government supported pharma-focused initiatives.

Specific themes and objectives will cover deployment of the key innovations and debating challenges facing the industry including the regulatory and commercial barriers to effectively deploy such broad transformational changes.

Advanced Therapies Integrates will become the leading UK event that facilitates the translation of cutting-edge research and disruptive innovation into the wide-spread adoption of Advanced Therapies, delivering improved patient outcomes and a revolution in healthcare economics.